Actively Targeting Redox-Responsive Multifunctional Micelles for Synergistic Chemotherapy of Cancer
Haile Fentahun Darge, Kefyalew Dagnew Addisu, Hsieh‐Chih Tsai, Yihenew Simegniew Birhan, Endiries Yibru Hanurry, Tefera Worku Mekonnen, Hailemichael Tegenu Gebrie, Vinothini Arunagiri, Darieo Thankachan, Tsung-Yun Wu, Juin‐Yih Lai, Hao-Ming Chang, Chun‐Chiang Huang, Szu‐Yuan Wu
Abstract
High Resolution Image Download MS PowerPoint Slide Stimuli-responsive polymeric micelles decorated with cancer biomarkers represent an optimal choice for drug delivery applications due to their ability to enhance therapeutic efficacy while mitigating adverse side effects. Accordingly, we synthesized a digoxin-modified novel multifunctional redox-responsive disulfide-linked poly(ethylene glycol- b -poly(lactic- co -glycolic acid) copolymer (Bi(Dig–PEG-PLGA)-S 2 ) for the targeted and controlled release of doxorubicin (DOX) in cancer cells. Within the micellar aggregate, the disulfide bond confers redox responsiveness, while the presence of the digoxin moiety acts as a targeting agent and chemosensitizer for DOX. Upon self-assembly in aqueous solution, Bi(Dig–PEG-PLGA)-S 2 formed uniformly distributed spherical micelles with a hydrodynamic diameter ( D h ) of 58.36 ± 0.78 nm and a zeta potential of −24.71 ± 1.01 mV. The micelles exhibited desirable serum and colloidal stability with a substantial drug loading capacity (DLC) of 6.26% and an encapsulation efficiency (EE) of 83.23%. In addition, the release of DOX demonstrated the redox-responsive behavior of the micelles, with approximately 89.41 ± 6.09 and 79.64 ± 6.68% of DOX diffusing from DOX@Bi(Dig–PEG-PLGA)-S 2 in the presence of 10 mM GSH and 0.1 mM H 2 O 2, respectively, over 96 h. Therefore, in HeLa cell lines, DOX@Bi(Dig–PEG-PLGA)-S 2 showed enhanced intracellular accumulation and subsequent apoptotic effects, attributed to the targeting ability and chemosensitization potential of digoxin. Hence, these findings underscore the promising characteristics of Bi(Dig–PEG-PLGA)-S 2 as a multifunctional drug delivery vehicle for cancer treatment.